European Heart Journal Advance Access originally published online on March 29, 2005
European Heart Journal 2005 26(10):956-959; doi:10.1093/eurheartj/ehi200
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A challenge to the metabolic approach to myocardial ischaemia
1Cardiac Muscle Research Laboratory, Boston University School of Medicine, Boston, MA, USA
2Hatter Institute for Heart Research, Cape Heart Center, University of Cape Town Medical School, Observatory 7925, South Africa
Received 7 February 2005; revised 11 February 2005; accepted 10 February 2005; online publish-ahead-of-print 29 March 2005.
* Corresponding author. Tel: +27 21 406 6358; fax: + 27 21 447 8789. E-mail address: Opie{at}capeheart.uct.ac.za
Abstract
The negative results of glucose-insulin-potassium (GIK) in the very large CREATE-ECLA trial that studied 20 201 patients with ST-elevation acute myocardial infarction (AMI), are disappointing and warrant thorough evaluation. We attempt to put the new data into perspective and uncover the serious flaws in the trial design, otherwise the whole metabolic concept will be disparaged. The crucial issue, developed from basic science data, is that GIK should be initiated very early, before, or at the time of reperfusion. Another problem with CREATE-ECLA is that the mortality in Killip class 1 reperfused patients was 7.1%, much higher than that of a recent Dutch study in which mortality was only 1.2%. Nonetheless, there was a strong trend towards a lower mortality in the sub-groups that received the best reperfusion therapy in CREATE-ECLA, as well as in the first of two rather small Dutch GIK trials. In the future, the ideal protocol to test would be if GIK were given in the ambulance as the patient is being transported to a specialized centre of percutaneous coronary intervention (PCI), with the aim of expanding the time window between pain onset and actual PCI.
Key Words: Metabolic therapy • Glucose-insulin-potassium • Acute myocardial infarction • Reperfusion
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Bertrand, S. Horman, C. Beauloye, and J.-L. Vanoverschelde Insulin signalling in the heart Cardiovasc Res, July 15, 2008; 79(2): 238 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Zuurbier, F. J. Hoek, J. van Dijk, N. G. Abeling, J. C. M. Meijers, J. H. M. Levels, E. de Jonge, B. A. de Mol, and H. B. Van Wezel Perioperative hyperinsulinaemic normoglycaemic clamp causes hypolipidaemia after coronary artery surgery Br. J. Anaesth., April 1, 2008; 100(4): 442 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Yellon and D. J. Hausenloy Myocardial Reperfusion Injury N. Engl. J. Med., September 13, 2007; 357(11): 1121 - 1135. [Full Text] [PDF]
|
|
|
|
 |
|
 H. B. Van Wezel Glucose-insulin-potassium techniques in cardiac surgery: historical overview and future perspectives. Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2006; 10(3): 224 - 227. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Wexler and J. S. Ingwall Carl S. Apstein, MD: 1941-2005 Circulation, August 22, 2006; 114(8): 867 - 868. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Vogelzang and F. Zijlstra Glucose metabolism and acute myocardial infarction Eur. Heart J., June 1, 2006; 27(11): 1264 - 1265. [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Timmer, T. Svilaas, J. P. Ottervanger, J. P.S. Henriques, J.-H. E. Dambrink, S. A.J. van den Broek, I. C.C. van der Horst, and F. Zijlstra Glucose-Insulin-Potassium Infusion in Patients With Acute Myocardial Infarction Without Signs of Heart Failure: The Glucose-Insulin-Potassium Study (GIPS)-II J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1730 - 1731. [Full Text] [PDF]
|
|